• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during pregnancy and breastfeeding is challenging for women with the condition. There are few data on how exposure to Adhd medication Pregnancy for a long time could affect a fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to adhd depression medication medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to consider the benefits of taking it versus the risks for the baby. The doctors don't have the information to make unambiguous recommendations, but can provide information on risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not face an increased risk of fetal heart malformations or major structural birth defects. Researchers conducted a massive population-based case control study to compare the incidence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to make sure that the classification was accurate and to reduce any bias.

The research conducted by the researchers had some limitations. Most important, they were not able to differentiate the effects of the medication from the disorder that is underlying. This limitation makes it difficult to determine whether the limited associations observed in the groups that were exposed result from medication use or confounding by comorbidities. The researchers also did not examine the long-term effects for the offspring.

The study did show that babies whose mothers had taken ADHD medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. The reason for this was central nervous system disorders, and the increased risk for admission was not found to be influenced by which stimulant medications were used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases didn't appear to be affected by the kind of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during early pregnancy may be offset by the greater benefit to both mother and child of continuing treatment for the woman's condition. Physicians should discuss the issue with their patients and, if possible, help them develop strategies to improve their coping abilities which can reduce the negative impact of her condition on her daily life and relationships.

Interactions with Medication

As more women than ever before are being diagnosed with ADHD and treated with medication, the dilemma of whether to keep or discontinue treatment during pregnancy is one that doctors are having to face. These decisions are often made without clear and authoritative evidence. Instead, doctors have to consider their own expertise in conjunction with the experiences of other physicians and the research that has been conducted on the subject.

Particularly, the issue of potential risks for the baby can be tricky. Many of the studies on this subject are based on observational evidence rather than controlled research and their conclusions are often contradictory. Most studies focus on live births, which can underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study presented in the journal club addresses these issues by analyzing both data on live and deceased births.

Conclusion Some studies have found an association between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. Most studies show an unintended, or somewhat negative, impact. In the end an accurate risk-benefit analysis is required in every case.

It can be challenging, if not impossible for women suffering from ADHD to stop taking their medication. In an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness, and family conflict for patients with ADHD. The loss of medication can also impact the ability to safely drive and perform work-related tasks, which are vital aspects of normal life for people with ADHD.

She suggests women who are uncertain about whether or not to stop medication in light of their pregnancy consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily life, and the advantages of continuing the current treatment regimen. It can also help women feel confident about her decision. It is important to remember that certain medications can be absorbed through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can be transferred to the child.

Birth Defects Risk

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about the effects that the drugs could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this issue. With two massive data sets researchers were able analyze more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increase in the risk of certain heart defects, such as ventriculoseptal defect (VSD).

The authors of the study could not discover any connection between the use of early medications and other congenital anomalies such as facial deformities or club feet. The results are in line with previous studies that showed the existence of a slight, but significant increase in cardiac malformations for women who began taking ADHD medication before the birth of their child. The risk increased in the latter part of pregnancy, when a lot of women decided to stop taking their best medication for adhd and anxiety.

Women who used ADHD medications during the first trimester of their pregnancies were also more likely to experience a caesarean section, a low Apgar score following delivery, and a baby who needed help breathing at birth. The researchers of the study were not able to remove bias in selection since they limited the study to women without other medical conditions that could have contributed to the findings.

The researchers hope their research will help inform the clinical decisions of physicians who encounter pregnant women. They advise that while a discussion of the benefits and risks is important but the decision to stop or continue medication must be based on each woman's requirements and the severity of her adhd medication and pregnancy uk symptoms.

The authors also advise that, while stopping the medication is an option, it isn't a recommended practice because of the high rate of depression and other mental health issues in women who are pregnant or who are recently postpartum. Additionally, research suggests that women who stop taking their medication will have a harder adjustment to life without them once the baby is born.

Nursing

It can be overwhelming to become a mom. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments and making preparations for the arrival of a child and adapting to new routines in the home can experience severe challenges. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant medicines are absorbed through breast milk in very small amounts, therefore the risk for infant who is breastfeeding is low. The rate of medication exposure will differ based on dosage and frequency of administration as well as time of day. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn infant is not fully known.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the lack of research. This is a difficult decision for the patient, who prescribes adhd medication must balance the benefit of continuing her medication against the potential dangers to the foetus. In the meantime, until more information is available, doctors may ask pregnant patients if they have an background of ADHD or if they plan to take medication during the perinatal stage.

A increasing number of studies have proven that most women can safely continue taking their ADHD medication while they are pregnant and nursing. In the end, an increasing number of patients opt to do this and, in consultation with their physician, they have discovered that the benefits of keeping their current medication far exceed any risk.

Women who suffer from ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD be aware of the symptoms and underlying disorder. They should also learn about treatment options and reinforce strategies for coping. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counselling should include the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.